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Abstract 
Circadian clock genes regulate energy metabolism partly through neurotrophins in the 
body. The low affinity neurotrophin receptor p75
NTR
 is a clock component directly 
regulated by the transcriptional factor Clock:Bmal1 complex. Brain-derived 
neurotrophic factor (BDNF) is expressed in the brain and plays a key role in 
coordinating metabolic interactions between neurons and astrocytes. BDNF transduces 
signals through TrkB and p75
NTR 
receptors. This review highlights a novel molecular 
mechanism by which BDNF via circadian control of p75
NTR
 leads to daily resetting of 
glucose and glycogen metabolism in brain astrocytes to accommodate their functional 
interaction with neurons. Astrocytes store glycogen as an energy reservoir to provide 
active neurons with the glycolytic metabolite lactate. Astrocytes predominantly express 
the truncated receptor TrkB.T1 which lacks an intracellular receptor tyrosine kinase 
domain. TrkB.T1 retains the capacity to regulate cell morphology through regulation of 
Rho GTPases. In contrast, p75
NTR
 mediates generation of the bioactive lipid ceramide 
upon stimulation with BDNF and inhibits PKA activation. As ceramide directly 
activates PKCζ, we discuss the importance of the TrkB.T1-p75NTR-ceramide-PKCζ 
signaling axis in the stimulation of glycogen and lipid synthesis and activation of RhoA. 
Ceramide-PKCζ-casein kinase 2 signaling activates Nrf2 to support oxidative 
phosphorylation via upregulation of antioxidant enzymes. In the absence of p75
NTR
, 
TrkB.T1 functionally interacts with adenosine A2AR and dopamine D1R receptors to 
enhance cAMP-PKA signaling and activate Rac1 and NF-κB c-Rel, favoring glycogen 
hydrolysis, gluconeogenesis and aerobic glycolysis. Thus, diurnal changes in p75
NTR
 
levels in astrocytes resets energy metabolism via BDNF to accommodate their 
metabolic interaction with neurons.  
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1. Introduction 
The master biological clock, which entrains the whole body clock, is believed to 
reside in the suprachiasmatic nucleus (SCN) in mammals. Although the master clock 
entrains the whole body rhythm, peripheral tissues also express core clock transcription 
factors Clock and Bmal1 which regulate expression of clock genes including Period 
(Per) and Cryptochrome (Cry) proteins. Complexes of Per and Cry proteins repress 
Bmal1- and Clock-mediated transcription forming a negative feedback loop, which 
regulates nearly a 24 h self-sustained rhythm including energy metabolism [1,2](Fig. 1 
A).  
Period2 (Per2) plays a key role in the regulation of metabolic and cardiovascular 
circadian rhythms [3,4]. The peripheral clock in nocturnal animals has a time shift from 
the master clock in the SCN to adapt to increases in energy expenditure during the 
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dark/active phase. Per2 clock gene expression significantly differs between the SCN and 
other parts of brain and peripheral tissues in rat [5,6]. Notably, the peak of Per2 protein 
is significantly delayed to that of mRNA. Immunostaining of brain sections show that 
the Per2 protein rhythm is synchronized among cells including neurons and glial cells. 
Per2 protein levels peak around the Zeitgeber time 1 (ZT1, early light/rest phase) and 
exhibit a sharp nadir around ZT13 (early dark/active phase) in the basolateral amygdala, 
the dentate gyrus and the dorsal striatum [5,7] (Fig. 1 B). 
Neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth 
factor (NGF) are produced in various neuronal and non-neuronal cells, leading to 
autocrine and paracrine regulation of energy metabolism to support cell survival, growth, 
differentiation and other functions (reviewed in [8-10]). The diverse actions of 
neurotrophins are mediated through two different transmembrane receptors, the 
common low affinity p75 neurotrophin receptor (p75
NTR
) and neurotrophin-specific 
high affinity Trk (tropomyosin-related kinase) A, B and C receptors. The former 
receptor belongs to the tumor necrosis factor receptor superfamily [11]. Recently, 
Baeza-Raja et al. found that p75
ntr 
gene expression is directly controlled by the 
heteromeric Clock:Bmal1 master circadian transcription factor through its E-box 
enhancers (Fig. 1 A) and that the phases of p75
NTR
 and Per2 mRNAs are synchronized 
with peaks at around ZT16 in mouse liver [12]. Compared to Per2 protein, there are no 
precise data showing the daily variation of p75
NTR
 protein expression levels in brain 
areas. However, the transcription rates of both p75
NTR
 and Per2 genes via Clock-Bmal1 
will be maximal around ZT13 when the Per2 protein levels are minimal [5,7] (Fig. 1B). 
Considering Per2 mRNA and protein respectively peaked around ZT19 and ZT1 in 
dorsal striatum [7], we can predict that the p75
NTR
 protein levels will peak between late 
dark/active phase and early light/rest phase in the brain areas. To discuss detailed daily 
variation of BDNF-TrkB.T1-p75
NTR
 signaling pathways, precise determination of 
BDNF, TrkB.T1 and p75
NTR
 protein levels as well as their distribution and activation 
states in astrocytes in the brain areas will be required.  
p75
NTR
-mediated signaling plays a key role in daily changes in energy metabolism in 
p75
NTR
 expressing tissues including liver, muscle, adipose and brain. Notably, p75
NTR
 
positively regulates lipogenesis in the liver and loss of p75
NTR
 in mice results in the 
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resistance to high fat diet-induced obesity with enhanced insulin sensitivity [13,14]. 
However, the detailed signaling pathways regulated by p75
NTR
 remain to be fully 
elucidated.  
As BDNF is enriched in adult brain, with particularly high levels in the hippocampus 
and cerebral cortex, it is recognized as an important regulator of neuronal plasticity and 
memory formation (reviewed in [15,16]). BDNF acts on both neurons and astrocytes 
and regulates formation of neuronal synapses as well as glucose and lipid metabolism in 
astrocytes, thereby underpinning metabolic interactions between astrocytes and neurons 
(reviewed in [9,10,17,18]) (Fig. 1 C).  
In this review, we focus on the molecular mechanisms by which BDNF-mediated 
signaling pathways are affected by daily variation in p75
NTR
 levels in astrocytes. We 
highlight the differential signaling pathways modulated by the TrkB-p75
NTR
 complex 
versus TrkB without p75
NTR
 in the regulation of energy metabolism. Notably, the 
metabolic changes are coupled with dynamic alterations in cell morphology and oxygen 
metabolism in astrocytes. These changes in astrocytes are critical for time-dependent 
sharing of oxygen and glucose with neurons.  
 
2. Astrocytes metabolically support neurons  
Glucose is the predominant energy substrate of the central and peripheral nervous 
system. The majority of glucose is transported to brain via the facilitative transporter 
GLUT1 expressed in capillary endothelial cells and astrocytes (reviewed in [19]). 
Neurons express GLUT3 in addition to GLUT1 [20]. Compared to GLUT1, GLUT3 has 
a higher affinity for glucose and a significantly greater capacity to transport glucose, 
providing neurons with preferential access to available glucose (reviewed in [21]). In 
the mammalian brain, astrocytes exceed the number of neurons and are intimately 
involved in signal transmission, responding to and influencing neuronal activity. 
Consequently, astrocytes play important roles in synaptic function and the delivery of 
nutrients from the circulation to neurons (reviewed in [22-26]).  
Astrocytes store glycogen as an energy store in times of nutritional sufficiency for 
utilization in times of need. Transported glucose and glycogen derived 
glucose-6-phosphate are initially converted to pyruvate during glycolysis and pyruvate 
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is completely oxidized in the tricarboxylic acid (TCA) cycle. When neurons are 
activated astrocytes synthesize neurotransmitter glutamate which is transferred to 
neurons through glutamine-glutamate cycle to support neuronal activity. Glycolytically 
derived energy is required for this process in both neurons and astrocytes. As glycolysis 
raises cytosolic redox potential (NADH > NAD
+
), excess pyruvate, not used for TCA 
cycle, is preferentially converted to lactate as this reaction oxidizes NADH back to 
NAD
+
 (reviewed in [27]). 
Astrocytes flexibly change energy metabolism such as glycogen synthesis and 
hydrolysis, and increase in glycolysis in response to nutritional status, hormonal 
stimulation and the energy demands of neurons and astrocytes themselves (reviewed in 
[28,29]. For example, intense physical exercise is known to cause depletion of glycogen 
in skeletal muscles and liver, and under such conditions rat brain glycogen also 
significant decreases with increase in production of lactate [30]. Serotonin plays a key 
role in the glycogen mobilization during exercise and the brain glycogen recovers in 6 h 
after cessation of exercise [31,32]. Brain glucose metabolism also changes during the 
sleep-wake cycle. During wakefulness, norepinephrine-dependent high rates of aerobic 
glycolysis and lactate production in both neurons and astrocytes, and glycogen 
hydrolysis in astrocytes can be observed. Lactate in turn potentiates norepinephrine 
release by noradrenergic terminals (reviewed in [33]).  
Although astrocytes change their metabolism in response to extracellular stimuli, the 
cellular clock governs the daily rhythm of metabolism to save or efficiently expend 
energy. As the p75
NTR
 receptor is a clock component and BDNF is the major 
neurotrophin, the BDNF-p75
NTR
 signaling axis seems to play an important role in the 
daily rhythm of brain metabolism and the metabolic cooperation between astrocytes and 
neurons. Disturbances in neuron-astrocyte metabolic cooperation have been linked with 
impaired long-term memory, synaptic plasticity, cognition and ultimately 
neurodegeneration (reviewed in [34-36]). Thus, understanding how BDNF coordinates 
metabolic interactions between astrocytes and neurons has emerged as an important 
research field.  
 
3. Molecular functions of BDNF receptors expressed in astrocytes 
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The diverse actions of BDNF are mediated through TrkB and p75
NTR 
receptors. The 
TrkB receptor has a higher affinity for BDNF than p75
NTR
, but the two receptors usually 
work together in multiple intracellular signaling pathways triggered by BDNF. Notably, 
astrocytes exclusively express a truncated TrkB.T1, which lacks the intracellular 
tyrosine kinase domain and hence transduces restricted intracellular signals compared to 
the full size TrkB [37]. This is an important point in comparing BDNF signaling 
pathways in astrocytes with those in neurons, which express full size TrkB in addition to 
TrkB.T1.  
 
3.1 TrkB.T1 signaling regulates cell morphology via RhoGTPase 
A notable function of BDNF is regulation of cell morphology through RhoGTPases, 
which rearrange the actin cytoskeleton through interaction with specific effectors 
(reviewed in [38,39]). Ohira et al. [37,40] found that TrkB.T1 associates with the Rho 
GDP dissociation inhibitor-1 (RhoGDI-1). RhoGDIs bind to geranyl lipids, attached at 
C-terminus of Rho GTPases and maintain them inactive (reviewed in [41,42]). 
Activation of Rho GTPases requires release from GDI to membrane and replacement of 
GDP to GTP by specific guanine nucleotide exchange factors (GEFs) before interaction 
with their effectors (Fig. 2 A and B). 
Specific activation of Rho GTPases can be achieved by phosphorylation of GDI by 
different kinases. Phosphorylation of GDI by PKCα at Ser-34 induces specific release of 
RhoA due to lowering its affinity for RhoA [43]. In contrast, phosphorylation of GDI 
with p21-activated kinase 1 (Pak1) specifically releases Rac1 [44] (Fig. 2 B).  
Cell shape changes are linked with the alterations in energy metabolism as will be 
discussed further in Sections 4.1 and 5.3. Previous studies show that an increase in 
cellular cyclic AMP (cAMP) induces a morphological change of an astrocyte from an 
epithelial-like to stellate morphology [45,46]. It has been reported that BDNF 
stimulation induces elongation of astrocytic processes [37,47], suggesting 
BDNF-TrkB.T1-mediated signals can induce an increase in cAMP and Rac1 activation 
(Fig. 2 C). The elongation of cell processes will increase contact areas with neuronal 
synapses. It is therefore important to clarify the mechanism by which BDNF-TrkB.T1 
regulated morphological changes in astrocytes affect metabolism and their functional 
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interaction with neurons.  
 
3.2 Two notable functions of p75
NTR
  
Baeza-Raja et al. [13] recently reported that p75
NTR
 directly interacts with PKA and 
inhibits its activation. This effect of p75
NTR
 is apparently not related to neurotrophins. 
Deficiency of p75
NTR
 accompanies increased cAMP and PKA activity causing an 
increase in lipolysis and energy expenditure in adipocytes [13]. These authors further 
concluded that the presence of p75
NTR
 favors lipogenesis in rat, but it remains unclear 
whether the neurotrophin-mediated signaling pathways contribute to lipogenesis in 
adipose tissues and liver. Although PKA also plays a key role in glycogen hydrolysis as 
will be discussed in Section 5.3, the effects of p75
NTR
-mediated signaling on glycogen 
metabolism have not been reported.  
The second notable function of p75
NTR
 is the generation of the lipid signaling 
molecule ceramide upon stimulation with neurotrophins involving activation of neutral 
sphingomyelinase [48]. Ceramide is involved in various biological responses including 
proliferation, differentiation and apoptosis [49]. As ceramide induces apoptosis at high 
concentrations, overstimulation of p75
NTR
 leads to apoptosis in neurons and glial cells 
[50]. However, the effects of physiological concentrations of ceramide generated 
through p75
NTR
 on metabolism and regulation of GTPases in astrocytes are not clear at 
present.  
A ceramide sensitive atypical protein kinase PKCζ mediates an important part of 
ceramide function [49]. Ceramide binds to and regulates kinase activity of PKCζ in a 
biphasic manner [51], noting that ceramide at 0.5-60 nM activates PKCζ, whereas 
concentrations above 60 nM decrease kinase activity to basal levels. Based on these and 
other studies, we discuss possible mechanisms by which p75
NTR
 participates in the 
regulation of metabolism and RhoGTPases via BDNF.  
 
4. Neurotrophin signaling via p75
NTR
  
To discuss the effects of variation in p75
NTR
 levels on metabolism, it is important to 
compare differences in metabolism between the two conditions, e.g. the presence and 
absence of p75
NTR
. The first step is to examine the signaling pathways regulated through 
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the p75
NTR
 receptor stimulation. 
 
4.1. Activation of RhoA via p75
NTR
 signaling  
Although previous studies show p75
NTR
 can activate RhoA through direct interaction 
with RhoGDI following stimulation with myelin-associated glycoprotein in neuronal 
cells [52,53], the effects of BDNF-TrkB.T1-p75
NTR
 signaling pathway in the modulation 
of Rho GTPases in astrocytes remain to be clarified. We propose a possible signaling 
pathway that p75
NTR
-mediated signals specifically activate RhoA via modification of 
RhoGDI by PKCα in astrocytes. We suggest p75NTR-ceramide-PKCζ signaling can 
induce Ca
2+
-influx via membrane depolarization leading to activation of PKCα (Fig. 3 
A).  
A notable function of PKCζ is to modulate the membrane potential through regulation 
of Shaker type voltage-activated potassium (Kv1) channels [54]. Kv1 channels are 
composed of membrane-spanning α subunits and cytoplasmic auxiliary β subunits, 
(Kvα)4(Kvβ)4 (Fig. 3A). A signal adaptor protein sequestosome-1 
(SQSTM1/ZIP/p62/A170), scaffolds PKCζ to help phosphorylate β-subunit of Kv1 
channels [54-56]. Furthermore, SQSTM1 is known as a regulator of p75
NTR
-mediated 
signaling. It directly interacts with p75
NTR
 and helps to transduce NGF-mediated signals 
in rat pheochromocytoma PC12 cells [57,58]. It was also shown that the NGF treatment 
upregulates SQSTM1 expression and activates PKCζ leading to modulation of Kv1 
channels in PC12 cells [59,60]. 
Astrocytes express Kvα1.5 type channels as the major Shaker type potassium channel 
[61]. Notably, the same PKCζ-SQSTM1-Kv1.5 signaling complex exists in mouse 
pulmonary arterial smooth muscle cells and functions in association with a sensor 
system to detect hypoxia [62]. Acute hypoxia-induced PKCζ-SQSTM1 mediated 
phosphorylation of Kv1.5 β subunits causes inhibition of Kv1.5 currents and local 
membrane depolarization leading to vasoconstriction of pulmonary arteries [62]. The 
hypoxia-induced inhibition of Kv1.5 currents are largely depended on PKCζ activation 
and increased generation of ceramide by neutral sphingomyerinase [63,64]. Local 
membrane depolarization increases Ca
2+
 influx through L-type voltage-gated calcium 
channels leading to vasoconstriction through RhoA activation in the smooth muscle 
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cells [62,65]. Depolarization-mediated Ca
2+
 influx activates PKCα and the 
ERK-dependent RhoGEF-H1 resulting in RhoA activation [66]. In astrocytes, the 
PKCζ-SQSTM1-Kv1.5 signaling complex can be associated with TrkB.T1-p75
NTR
 
receptor complex and transduce signals when ceramide is generated following BDNF 
binding to the receptor (Fig. 3 A).  
 
4.2 Activation of casein kinase 2 and Nrf2 via p75
NTR
 signaling 
Kosaka et al. [67] showed NGF treatment induces activation of transcription factor 
Nrf2 in PC12 cells. Nrf2 is a master regulator for the cellular defense against oxidative 
stress (see recent FRBM Special Issue on Nrf2 [68]). Nrf2 positively regulates 
expression of many genes including detoxifying phase II and antioxidant enzymes and 
proteins [69-71]. However, the precise mechanism how NGF activates Nrf2 has not 
been elucidated. Meanwhile, neurotrophins such as NGF, BDNF and neurotrophin-4 
(NT-4) activate casein kinase 2 (CK2) in rat hippocampal slices or neurons [72,73] and 
that p75
NTR
 is required for CK2 activation in mouse hippocampal neurons following 
stimulation with NGF [74] (Table 1, part 1). CK2 is highly expressed in the mammalian 
brain and has many substrates important for neuronal or glial homeostasis and synaptic 
signaling processes (reviewed in [75]).  
Activation of Nrf2 can be regulated via multiple mechanisms, and the Kelch-like 
ECH-associated protein 1 (Keap1)-mediated indirect regulation of Nrf2 stability by 
electrophiles is the most characterized pathway [76]. Direct modifications of Nrf2 by 
kinases also regulate stability and nuclear translocation of Nrf2. For instance, 
Ca
2+
-regulated PKC directly phosphorylates Nrf2 and transitory enhances 
ARE-mediated gene expression [77]. Additionally, Nrf2 has multiple phosphorylation 
sites for CK2 in the Neh4 and Neh5 transcription activation domains and 
phosphorylation by CK2 stabilizes/activates Nrf2 [78,79]. CK2-mediated activation of 
Nrf2 was previously observed in cells stimulated with oxidized phospholipids and 
tert-butyl-hydroquinone (tBHQ) [79,80] (Table 1, part 2). Although tBHQ can also 
target Keap1 Cys-151 to activate Nrf2 [76], tBHQ-CK2-Nrf2 axis contributes much 
more for the Nrf2 stabilization [78-80]. It is noted that a kinase inhibitor LY294002 is 
known as a PI3K inhibitor but also potently inhibits CK2, and that Afonyuskin et al. 
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[80] showed PI3K-specific inhibitor wortmannin hardly inhibits Nrf2 activation by 
oxidized phospholipids in human endothelial cells. These studies strongly support an 
idea that neurotrophin-p75
NTR
-CK2 axis induces Nrf2 activation. 
CK2 contributes to the growth and survival of malignant gliomas and has been 
considered as a therapeutic target in these tumors [81-83]. Although direct correlation 
between CK2 activity and Nrf2 activation among gliomas is currently unproved, Nrf2 
target genes are elevated in some of the gliomas [84]. Interestingly, Cong et al. (2013) 
[85] showed that the kinase inhibitor LY294002 suppressed Nrf2 activity in human 
glioblastoma U251 cells (Table 1. Part 2). The authors argued that PI3K signaling 
pathway partly regulate Nrf2 activation, however, it is possible that CK2 activity 
contributes enhanced Nrf2-mediated defense system in the glioblastoma cell line as 
LY294002 also inhibits CK2 activity,.  
Astrocytes have a high capacity to upregulate the Nrf2/ARE system. Kraft et al. 
stimulated fresh brain astrocytes from mouse embryos with tBHQ, and observed about 
80 genes were upregulated through an ARE-dependent manner [86].  Those included 
typical Nrf2 target genes important in glucose and fatty acid metabolism, glutathione 
synthesis and detoxification [86]. Genes encoding Glucose-6-phosphate dehydrogenase 
[87], glycogen branching enzyme [88] and SQSTM1 (A170) [70] were included in the 
activated genes by tBHQ in the astrocytes [86]. Glucose-6-phosphate dehydrogenase is 
a key enzyme for the production of NADPH through the pentose phosphate pathway 
[86]. NADPH is important not only for reductase systems but also for fatty acid and 
cholesterol synthesis. Recent studies have revealed that Nrf2 is indispensable for 
mitochondrial activity such as fatty acid oxidation and ATP production and for 
mitochondrial integrity by promoting mitophagy (reviewed in [89,90]).  
 
4.3 Ceramide-mediated CK2 and Nrf2 activation 
The precise mechanism of CK2 activation by p75
NTR
-mediated signaling is not 
known. We suggest the importance of PKCs for CK2 activation as a previous study 
shows conventional and atypical PKCs including PKCα and PKCζ are able to 
phosphorylate and activate CK2α and CK2β [91]. Notably, NGF treatment actually 
produces ceramide, and C6-ceramide replaces NGF in the protection of sympathetic 
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neurons [92]. In another study, supplementing cell-permeable short-chain C2-ceramide 
to the culture medium provoked Nrf2/ARE signaling pathways in rat primary astrocytes 
[93]. Therefore, we propose that p75
NTR
-ceramide activated PKCζ and 
depolarization/Ca
2+
-influx activated PKCα contribute in activation of CK2/Nrf2 
pathway following treatment with BDNF and other neurotrophins in astrocytes (Fig. 
3B).  
Although the mechanism how tBHQ activates CK2 is not known, other Nrf2 
activating agents such as low density lipoproteins and/or oxidized phospholipids are 
reported to stimulate sphingomyelin-ceramide pathway in smooth muscle cells, 
endothelial cells and macrophages [94-96]. These cells are able to sense oxidized lipids 
through increase in ceramide generation, suggesting a possible link of the 
ceramide-PKCζ system with CK2/Nrf2 activation by low levels of oxidized 
phospholipids. It is also noted that Nrf2 activating natural phenolic compounds 
resveratrol and curcumin are known to produce ceramide in cells and that their 
anti-cancer activity partly depends on ceramide-induced growth inhibition and apoptosis 
[98-102] (Table 2).  
Notably, the activation of Nrf2 by p75
NTR
-CK2 axis is neither mediated through 
Keap1 modification nor directly related with oxidative stress, but is programed by the 
cellular clock which predicts and prepares forthcoming metabolic changes. Of course 
many other Nrf2 activating metabolites will be produced during a high cellular activity, 
but the prior upregulation of Nrf2-regulated gene products via p75
NTR
-CK2 axis will 
reduce production of insulting metabolites.  
 
4.4. Expected metabolic changes via p75
NTR
-CK2 signaling  
Currently, studies on the roles of p75
NTR
 and CK2 in the energy metabolism in 
normal astrocytes in the brain are limited. However, we can speculate from previous 
studies with cultured cells and tissues that activation of CK2 could phosphorylate and 
inactivate PTEN (phosphatase and tensin homologue) causing an increase in PIP3 levels 
resulting in Akt/PKB activation [103,104]. CK2 also enhances Akt activity through a 
direct interaction [105], and notably Akt can activate mTORC1 leading to lipogenesis 
(reviewed in [106]). Akt phosphorylates and inhibits glycogen synthase kinase-3 β 
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(GSK3β) [107]. These signaling pathways are also expected to occur via CK2 activation 
in astrocytes (Fig. 3B). 
As PKA plays an important role in glycogen hydrolysis, inhibiting PKA by p75
NTR
 
will benefit for glycogen synthesis. Protein phosphatase-1 (PP1), which is indirectly 
inhibited by PKA [108], plays a key role in glycogen synthesis through activation of 
glycogen synthase and inactivation of glycogen phosphorylase kinase and glycogen 
phosphorylase (reviewed in [109]). Additionally, inhibition of GSK3β via the CK2 
signaling pathway will partly contributes to glycogen synthesis (Fig. 3B). 
 
5. TrkB.T1-mediated regulation of metabolism  
In the absence of p75
NTR
, BDNF-TrkB.T1 signaling pathways are quite different from 
those governed by ceramide and PKA inhibition. As the TrkB.T1 receptor lacks a 
tyrosine kinase domain, BDNF-mediated signaling through this receptor is restricted. 
Therefore, cross-talk of TrkB.T1 with other receptors that activate PKA is thought to 
influence the transduction of BDNF signals.  
 
5.1 Crosstalk of TrkB.T1 with adenosine A2A receptor 
In neurons, interaction of TrkB with the adenosine A2AR receptor has been reported 
[110,111]. Interestingly, adenosine stimulation via A2AR can induce TrkB signaling in 
the absence of BDNF. Moreover, BDNF can facilitate A2AR signaling in neurons via 
transactivation. It has been suggested that A2AR-mediated activation of PKA induces 
translocation of TrkB receptors to lipid rafts [111]. In addition to BDNF, adenosine is a 
well-known modulator of synaptic maturation, plasticity and signaling [112]. Adenosine 
can be released from presynaptic vesicles but an increase in extracellular adenosine can 
also be produced from released ATP by ecto-nucleotidases (reviewed in [113,114]). The 
A2AR receptor is associated with Gαs protein and upregulates cAMP via activation of 
adenylyl cyclase. Astrocytes mainly express A2AR which contribute to neuronal 
excitability [115]. Based on these studies, we predict that TrkB.T1 also functionally 
interacts with A2AR in astrocytes (Fig. 3). 
 
5.2 Functional interaction of TrkB.T1 with dopamine D1 receptor 
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In addition to A2AR, dopamine D1 receptor (D1R) also functionally interacts with 
TrkB in neurons. Iwakura et al. [116] studied the mechanism by which dopamine via 
D1R regulates neurite outgrowth and morphological changes in primary neurons. They 
found that a D1R agonist increased TrkB-mediated signaling through enhanced surface 
expression of TrkB. D1R also associates Gαs like A2AR and activates cAMP/PKA 
signaling upon stimulation with dopamine. As astrocytes express D1R at high levels 
[117], dopamine may also affect TrkB.T1 functions.  
Dopamine is a neurotransmitter involved in modulation of attention, motivation, 
learning, and memory consolidation [118,119]. Mid brain dopaminergic neurons send 
numerous projections to the prefrontal cortex and dorsal and ventral striatum, and 
diffusely released dopamine participates in both synaptic and extra-synaptic 
transmission [120,121]. Dopamine enhances glycogenolysis in brain [122]. Application 
of dopamine to the culture medium (1 μM) actually induces activation of the D1R-PKA 
signaling pathway in astrocytes within a few minutes leading to an increase in glycogen 
hydrolysis and glycolysis [123]. Notably, dopamine levels in the dorsal striatum exhibit 
a clear daily rhythm: minimal around ZT6 and maximal around ZT18 [7]. These results 
indicate that DA released from dopaminergic neurons could act on astrocytes to boost 
glycogen hydrolysis more efficiently during the dark/active phase compared to the 
light/rest phase. 
 
5.3 PKA enhances glycogen hydrolysis and cell process extension 
PKA plays a key role in glycogen hydrolysis. PKA phosphorylates DARPP-32 which 
associates and inhibits PP1 [108]. PKA also phosphorylates glycogen synthase and 
glycogen phosphorylase kinase, which activates glycogen phosphorylase (reviewed in 
[109]) (Fig. 4 A). Additionally, PKA inhibits lipogenesis through direct phosphorylation 
of sterol regulatory element-binding protein (SREBP)-1a and -1c [124] and indirectly 
through mTORC1 inhibition [125].  
Rac1 can be activated by cAMP/PKA signaling [126,127]. Activated Rac1 associates 
its effector p21-activated kinase 1 (Pak1), which selectively releases Rac1 from the 
TrkB.T1-associated RhoGDI (Fig. 2 B and 4 B). Additionally, PKA can phosphorylate 
RhoA at Ser-188 to increase its affinity for RhoGDI resulting in RhoA inhibition [128] 
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(Fig. 4 B). The PKA-dependent reorganization of F-actin cytoskeleton via GTPases 
facilitates plasma membrane localization of the predominant water channel aquaporin 4 
(AQP4), and stable cAMP upregulation induces an increase in AQP4 total protein 
expression causing enhancement in water influx into astrocytes [129,130]. Increase in 
cell volume called swelling due to alteration of AQP4 expression and Rac1 activation 
will help extend astrocytic processes via filopodia and lameripodia formation resulting 
in the increase in astrocytic coverage over neuronal synapsis. 
 
5.4 PKA activates NF-κB c-Rel  
Another function of PKA is specific activation of a NF-κB component c-Rel. The 
c-Rel pathway induces expression of pro-survival factors such as Bcl-xL, manganese 
superoxide dismutase (MnSOD) and uncoupling protein 4 (Ucp4) in neuronal cells 
[131,132]. PKA inhibits degradation of IκB-α and suppresses IκB-α-dependent 
expression of IL-2, while increased synthesis of c-Rel and enhances IL-4 expression in 
T cells [133]. PKA enhances nuclear localization of c-Rel presumably by 
phosphorylation in T cells [134].  
Uncoupling proteins located in the inner membrane of mitochondria have been 
implicated in the suppression of oxidative phosphorylation and thermoregulation. 
Diminished ATP production is effectively compensated by enhanced glycolysis. A 
recent study by Ho et al. [132] showed that H2O2 activates c-Rel leading to induction of 
Ucp4 gene expression. Ucp4 is a brain-specific ucp expressed in astrocytes and neurons 
[135]. Upregulation of Ucp4 via c-Rel reduces production of H2O2 from mitochondria 
and thereby protects cells from oxidative damages while increasing lactate production in 
astrocytes [136]. As described above (Fig. 4 B), PKA activates Rac1 GTPase, which is 
known to activate NADPH oxidases (NOXs) [137,138]. NOX2 and NOX4 are widely 
expressed in central nervous system including neurons and astrocytes [139]. Although 
H2O2 activates c-Rel, the contribution of the Rac1-NOX signaling pathway in 
c-Rel-mediated Ucp4 expression is not clear at present. 
Aerobic glycolysis occurs during brain activation and is characterized by preferential 
up-regulation of glucose utilization compared with oxygen consumption even though 
oxygen level and delivery are adequate. Increased lactate production, lactate dispersal 
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from cells and lactate release from the brain are the major factors underlying aerobic 
glycolysis (reviewed in [140]). Astrocytes derive energy from both glycolysis and 
oxidative phosphorylation. Glycolysis and glycogenolysis are essential for astrocytic 
responses to increasing energy demand by neurons because astrocytic filopodial and 
lameripodial extensions, which account for 80% of their surface area, are too narrow to 
accommodate mitochondria [141]. Thus, the change in cell morphology and Ucp4 
upregulation through the PKA-Rac1 signaling axis is important for the enhancement of 
aerobic glycolysis in astrocytes. 
 
6. Sequential activation of CK2 and PKA controls circadian rhythm 
Regulation of circadian clock components by phosphorylation plays an essential role 
in clock functions and is conserved from fungi to mammals. Casein kinases and PKA 
mediate sequential phosphorylation events in the circadian negative feedback loop [142]. 
CK2 is an important regulator of Per protein in Drosophila [143]. CK2 binds and 
phosphorylates Per2, which supports nuclear accumulation of Per2 and affects stability 
of Per2 in mouse fibroblasts, and inhibition of CK2 activity disrupts circadian rhythm 
[144,145] (Table 1). Notably, CK2 suppresses activation of A2AR and D1R associated 
Gαs [146], Rac1 [147,148] and NOX [149] thereby downregulates PKA signaling (Table 
1).  
  PKA activation is also important for circadian phase control in mammals [150-152]. 
PKA activates cAMP-response elements binding proteins (CREBs) by phosphorylation. 
CREBs are nuclear factors acting as activators and repressors for target gene expression 
[153]. Notably, the cAMP-PKA-CREB signaling positively regulates gene expression of 
both BDNF and TrkB receptor in neurons [154,155]. In mouse liver, TrkB mRNA levels 
peak about 4 h earlier than p75
NTR
 mRNA levels [12]. These results suggest that both 
BDNF and TrkB are gradually upregulated during the dark/active phase and prepared 
for the phase change. 
  It has been shown that there is an autonomous circadian redox oscillation as observed 
in the S-sulfinylation of peroxiredoxins in cells [156] and that there is a cross-talk 
between circadian redox oscillations and metabolism [157]. The BDNF-mediated 
sequential activation of CK2-Nrf2 and PKA-c-Rel signaling pathways in astrocytes 
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provides a cell-type specific example of the coupling of redox rhythm with cellular 
metabolism. We propose that circadian control of p75
NTR
 expression plays a key role in 
in rhythmic respiration and redox homeostasis in cerebral astrocytes.  
 
7. Summary: Circadian rhythm switches metabolism via BNDF in astrocytes  
Figure 5 summarizes our working model by which circadian control of p75
NTR
 
expression drives metabolic switching in the sleep-wake cycle in astrocytes. The 
BDNF-p75
NTR
-ceramide-CK2 signaling promotes anabolism, favoring storage of energy 
in the form of glycogen and lipid. This signaling axis activates Nrf2 to back up 
mitochondrial oxidative phosphorylation to efficiently synthesize ATP when neuronal 
activity remains at low levels. Ceramide-PKCζ signaling activates RhoA to cause 
shortening of cell processes thereby reducing the astrocyte’s nursing activity. When the 
p75
NTR
 expression decreases, the BDNF-TrkB.T1-mediated signaling axis in turn 
activates cAMP-PKA to enhance catabolism. This signaling axis can be enhanced by 
stimulation of adenosine-A2AR and dopamine-D1R signaling pathways. PKA-mediated 
signaling specifically activates NF-κB component c-Rel and elongation of processes 
(Fig. 2 C and 4 B). PKA-mediated signaling enhances production of glucose from 
glycogen and upregulated Ucp4 increases production of lactate while reducing oxygen 
consumption in astrocytes to support high neuronal activity. 
Recent studies have revealed time-dependent changes in the functional and metabolic 
interaction between astrocytes and neurons in the SCN of the hypothalamus [158,159], 
where the rhythm has a diametrically opposite phase compared to other brain areas in 
mice. Brancaccino et al. [159] monitored intracellular calcium oscillations in SCN 
neurons and astrocytes and found that they behaved in an anti-phasic manner. The SCN 
neurons are active during circadian daytime, while SCN astrocytes are active during 
circadian nighttime. The astrocytes release metabolites in the extracellular space to 
inhibit neuronal activation during nighttime. Ablation of Bmal1 in the SCN astrocytes 
lengthened the circadian period of clock gene expression in the SCN, suggesting the 
importance of astrocytes in determining circadian rhythms [158]. In contrast, 
BDNF-TrkB signaling or TrkB tyrosine kinase activity in the SCN neurons, which is 
required in light-induced circadian clock phase-resetting [160,161], is important to 
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induce daily rhythm of morphological change in astrocytes. Under the normal TrkB 
function in the neurons, astrocytic contact areas over dendrites of vasoactive intestinal 
peptide-producing neurons increase roughly two-fold in early daytime (ZT2) compared 
to mid nighttime (ZT18) in mice [162]. These studies indicate the importance of a 
time-dependent shift of interaction between astrocytes and neurons for biological 
timekeeping. 
The maintenance of time-phase and amplitude of p75
NTR
 expression together with the 
rhythmic expression of TrkB.T1 and BDNF serve as important factors for augmentation 
of both glycogen storage in astrocytes and release of glucose and lactate from astrocytes 
to support neuronal activity and survival. Disturbances in circadian rhythms and sleep 
cycles have been considered as symptoms of aging-related neurodegenerative 
conditions (reviewed in [163-166]. Circadian rhythm dysfunction is often observed in 
patients with Alzheimer’s, Parkinson’s and Huntington disease. Clinical studies and 
experiments in animal models of neurodegenerative disorders have revealed the 
progressive nature of circadian dysfunction throughout the course of neurodegeneration. 
As disruption of the circadian rhythm may accompany reduction of glycogen storage in 
the brain, manipulation of circadian clock and sleep-wake cycles may promote the 
normal glycogen-glucose cycle and hence healthy brain aging.  
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Legend to figures 
 
Figure 1. Neurotrophin receptor p75
NTR
 is a clock component involved in circadian 
control of BDNF-mediated metabolism in astrocytes and neurons. A, Expression of 
p75
NTR
 is directly controlled by Clock:Bmal1 complex similar to another clock gene 
Per2 [12]. B, Per2 protein expression in the cerebrum has a peak in early light/rest phase 
and a trough in early dark/active phase. C, Astrocytes store glycogen and feed lactate 
and other metabolites to neurons to support their activities. BDNF coordinates the 
metabolic interaction between astrocytes and neurons. 
 
Figure 2. TrkB.T1 facilitates regulation of Rho GTPases. A, TrkB.T1 binds RhoGDI 
that keeps RhoGTPase in an inactive form [37,40]. BDNF-mediated activation of Rho 
GTPases requires transfer to membrane, GTP binding and interaction with their 
effectors. RhoA, Rac1 and Cdc42 are the major Rho GTPases that rearrange actin 
cytoskeleton. B, RhoGDI-associated RhoA and Rac1 can be preferentially transferred to 
the membrane by phosphorylation of RhoGDI with PKCα and Pak1 kinases, 
respectively. RhoGTPase-specific Rho-GEFs (guanine nucleotide exchange factors) 
activate RhoGTPases by exchanging GDP to GTP. C, Astrocytes change local and 
whole cell morphology depending on the activation state of RhoA and Rac1. RhoA 
facilitates process shortening, while Rac1 and Cdc42 promote process elongation via 
interaction with their specific effectors. Increase in cyclic AMP elongates cell processes 
leading to increase in contact areas with neuronal synapses. Activation of 
p75
NTR
-ceramide signaling induces RhoA activation. 
 
Figure 3. Signaling pathways stimulated by BDNF via TrkB.T1-p75
NTR
 receptor 
complex. Astrocytes exclusively express a truncated TrkB.T1 receptor that lacks the 
intracellular receptor tyrosine kinase domain. The low affinity p75
NTR
 inhibits PKA 
activation [13], and links with neutral sphingomyelinase to produce ceramide upon 
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stimulation [48]. BDNF stimulation through the receptor complex produces low levels 
of ceramide, which activates PKCζ. A, It is possible that activated PKCζ associates with 
sequestosome-1 (SQSTM1) and phosphorylates the β-subunits of Shaker type potassium 
Kv1.5 channels, causing local membrane depolarization and subsequent Ca
2+
 influx 
through L-type voltage-activated Ca
2+
 channels, and PKCα and RhoA activation 
(reviewed in [56]). B, Both PKCζ and PKCα phosphorylate and activate casein kinase 2 
(CK2), which then phosphorylates PTEN to inhibit its phosphatase activity leading to 
activation of Akt/PKB signaling [103,104]. Activated Akt phosphorylates and 
inactivates GSK3β which partly enhances glycogen synthesis. CK2 suppresses Gαs 
activation [146] and thus protein phosphatase-1 (PP1) remains active and enhances 
glycogen synthesis. CK2 also stabilizes/activates Nrf2 through direct phosphorylation 
[78,79].  
 
Figure 4. Functional interaction of TrkB.T1 receptor with adenosine receptor A2AR 
and dopamine receptor D1R leads to activation of PKA. A, In the absence of p75
NTR
, 
TrkB.T1 is proposed to interact with adenosine receptor A2AR and dopamine receptor 
D1R. Stimulation with BDNF, adenosine or dopamine is expected to increase cAMP via 
receptor-associated Gαs protein leading to activation of PKA. PKA plays a key role in 
glycogen hydrolysis through phosphorylation of DARPP-32, glycogen synthase and 
glycogen phosphorylase kinase. Phosphorylated DARPP-32 inhibits PP1. PKA also 
activates NF-κB c-Rel. B, Rac1 can be activated by cAMP/PKA signaling [126,127]. 
Rac1 then activates its effector Pak1 that selectively releases Rac1 from the 
TrkB.T1-associated RhoGDI (Fig. 2 B). Additionally, PKA phosphorylates RhoA to 
inactivate it.  
 
Figure 5. Clock regulated p75
NTR
 expression drives daily resetting of energy 
metabolism in astrocytes. We speculate that cell clock systems maximize p75
NTR
 
protein levels between in the late dark/active and early light/rest phase and minimize 
levels in the early dark/active phase. TrkB.T1-p75
NTR
-mediated signaling enhances 
RhoA activation, glycogen and lipid synthesis and Nrf2 activation. In contrast, under 
low p75
NTR
 expression, BDNF-TrkB.T1 signaling activates Rac1 and favors glycogen 
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hydrolysis, and activates c-Rel. Nrf2 upregulates phase II detoxification and antioxidant 
enzymes/proteins to support mitochondrial oxidative phosphorylation, while c-Rel 
upregulates MnSOD and Ucp4 to suppress superoxide production and oxidative 
phosphorylation in mitochondria leading to enhancement of glycolysis.  
 
 
 
Table 1. Neurotrophins-p75
NTR
-CK2 and CK2-Nrf2 signaling pathways 
(1) Neurotrophins activate CK2 and Nrf2 
Stimulants Tissues or Cells Results References 
NGF Rat pheochromocytoma PC12 Nrf2 activation [67]  
 
BDNF, NT-4 Rat hippocampal slices CK2 activation [72]  
BDNF Rat hippocampal neurons CK2 activation [73]  
NGF Rat hippocampal neurons p75NTR-dependent CK2 activation [74]  
 
(2) CK2-dependent Nrf2 activation  
Nrf2 activators or 
CK2 inhibitor 
Cells Experiments & Results References 
tBHQ, NaAsO2 Human epidermal HaCaT  CK2 inhibitor TBB inhibited Nrf2 
phosphorylation/activation  
[78]  
tBHQ Human neuroblastoma CK2 inhibitor DMAT inhibited Nrf2 activation, 
CK2 phosphorylated Nrf2 in vitro 
[79]  
Oxidized phospholipids, 
tBHQ 
Human umbilical vein 
endothelial cells 
LY294002 and CK2-specific inhibitors but not 
PI3K-specific inhibitor Wortmannin suppressed 
Nrf2 activation 
[80]  
LY294002 Human glioblastoma U251 Down-regulation of Nrf2 [85]  
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Table 2. Ceramide generation by Nrf2 activators 
 
Nrf2 activators Cells Results References 
NGF Rat sympathetic neurons p75NTR-dependent ceramide production, 
C6-ceramide replaces NGF for neuronal protection 
[92]  
Oxidized phospholipid  
and/or oxidized LDL 
 
 
Human/rabbit arterial smooth 
muscle cells 
Human macrophage 
Mouse RAW264.7 cells 
Human microvascular 
endothelial cells 
Neutral spingomyelinase-2 activation 
 
Ceramide formation 
Ceramide elevation and apoptosis 
Neutral spingomyelinase-2 activation 
[94]  
 
[95]  
[96]  
[97]  
resveratrol Human breast cancer cell 
 
Human prostate cancer cell 
Ceramide generation, growth inhibition and 
apoptosis induction  
Ceramide generation and growth inhibition  
[98]  
 
[99]  
curcumin Human colon cancer cell  
Human malignant glioma 
Human leukemia HL cells 
Robust ceramide generation 
Ceramide generation and cell death 
Bi-phasic ceramide generation 
[100]  
[101]  
[102]  
 
 
 
 
 
Highlights 
 
● Neurotrophin receptor p75NTR is a clock component regulating daily metabolic rhythm  
● BDNF-TrkBT.1-p75NTR signaling favors glycogen synthesis in astrocytes 
● Stimulation of p75NTR generates ceramide which activates PKCζ 
● p75NTR-ceramide-PKCζ-CK2 signaling activates Nrf2 in astrocytes  
● PKCζ-SQSTM1 complex inhibits Kv1.5 currents inducing RhoA activation  
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